↓ Skip to main content

Dove Medical Press

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Readers on

mendeley
59 Mendeley
Title
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
Published in
International Journal of Chronic Obstructive Pulmonary Disease, February 2012
DOI 10.2147/copd.s27319
Pubmed ID
Authors

Donald P Tashkin, Dennis E Doherty, Edward Kerwin, Carlos E Matiz-Bueno, Barbara Knorr, Tulin Shekar, Sibabrata Banerjee, Heribert Staudinger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Australia 1 2%
Unknown 56 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 17%
Student > Bachelor 10 17%
Student > Master 7 12%
Other 6 10%
Student > Doctoral Student 4 7%
Other 10 17%
Unknown 12 20%
Readers by discipline Count As %
Medicine and Dentistry 27 46%
Nursing and Health Professions 5 8%
Unspecified 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Agricultural and Biological Sciences 2 3%
Other 6 10%
Unknown 15 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2016.
All research outputs
#8,534,528
of 25,373,627 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,053
of 2,577 outputs
Outputs of similar age
#74,738
of 253,530 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#6
of 16 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,530 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.